Aab Cardiovascular Research Institute (C.L., S.K.T., B.N.-L., S.K.B.-N., P.M., A.C.L., C.N.M.), University of Rochester School of Medicine and Dentistry, NY.
University of Puerto Rico, Medical Sciences Campus, San Juan (B.N.-L.).
Circ Res. 2024 Apr 12;134(8):970-986. doi: 10.1161/CIRCRESAHA.123.323662. Epub 2024 Mar 8.
While platelets have well-studied hemostatic functions, platelets are immune cells that circulate at the interface between the vascular wall and white blood cells. The physiological implications of these constant transient interactions are poorly understood. Activated platelets induce and amplify immune responses, but platelets may also maintain immune homeostasis in healthy conditions, including maintaining vascular integrity and T helper cell differentiation, meaning that platelets are central to both immune responses and immune quiescence. Clinical data have shown an association between low platelet counts (thrombocytopenia) and immune dysfunction in patients with sepsis and extracorporeal membrane oxygenation, further implicating platelets as more holistic immune regulators, but studies of platelet immune functions in nondisease contexts have had limited study.
We used in vivo models of thrombocytopenia and in vitro models of platelet and monocyte interactions, as well as RNA-seq and ATAC-seq (assay for transposase-accessible chromatin with sequencing), to mechanistically determine how resting platelet and monocyte interactions immune program monocytes.
Circulating platelets and monocytes interact in a CD47-dependent manner to regulate monocyte metabolism, histone methylation, and gene expression. Resting platelet-monocyte interactions limit TLR (toll-like receptor) signaling responses in healthy conditions in an innate immune training-like manner. In both human patients with sepsis and mouse sepsis models, thrombocytopenia exacerbated monocyte immune dysfunction, including increased cytokine production.
Thrombocytopenia immune programs monocytes in a manner that may lead to immune dysfunction in the context of sepsis. This is the first demonstration that sterile, endogenous cell interactions between resting platelets and monocytes regulate monocyte metabolism and pathogen responses, demonstrating platelets to be immune rheostats in both health and disease.
虽然血小板具有广泛研究的止血功能,但它们也是在血管壁和白细胞之间循环的免疫细胞。这些持续短暂相互作用的生理意义尚不清楚。活化的血小板可诱导和放大免疫反应,但在健康条件下,血小板也可能维持免疫稳态,包括维持血管完整性和辅助性 T 细胞分化,这意味着血小板是免疫反应和免疫静止的核心。临床数据表明,败血症和体外膜氧合患者的血小板计数降低(血小板减少症)与免疫功能障碍之间存在关联,这进一步表明血小板是更全面的免疫调节剂,但在非疾病情况下研究血小板免疫功能的研究有限。
我们使用了血小板减少症的体内模型和血小板与单核细胞相互作用的体外模型,以及 RNA-seq 和 ATAC-seq(用于转座酶可及染色质的测定与测序),以从机制上确定静止血小板与单核细胞的相互作用如何调节单核细胞的免疫程序。
循环血小板和单核细胞以 CD47 依赖性方式相互作用,以调节单核细胞代谢、组蛋白甲基化和基因表达。在健康条件下,静止血小板-单核细胞相互作用以类似于固有免疫训练的方式限制 TLR( toll 样受体)信号反应。在败血症患者和败血症小鼠模型中,血小板减少症均加剧了单核细胞的免疫功能障碍,包括细胞因子产生增加。
血小板减少症以一种可能导致败血症背景下免疫功能障碍的方式对单核细胞进行编程。这是首次证明静止的、内源性的血小板与单核细胞之间的细胞相互作用调节单核细胞代谢和病原体反应,表明血小板在健康和疾病中都是免疫变阻器。